OrthoPediatrics, a $98m producer of implants and devices that treat orthopedic conditions in children, is acquiring Canada-based Pega Medical, a developer of implant systems that treat bony deformities in children with osteogenesis imperfecta (brittle bone disease), for $33m. The acquisition adds to OrthoPediatrics’ range of technologies addressing unique conditions in pediatric orthopedics. Orthopediatrics acquired MD Orthopaedics, a producer of specialty …
Biosynth Carbosynth Acquires Aalto Bio Reagents
Biosynth Carbosynth, a provider of life science research products and contract manufacturing services, has purchased Ireland-based Aalto Bio Reagents, a supplier of biological materials serving the in-vitro diagnostic (IVD) and vaccine development markets. In March 2022, Biosynth acquired vivitide, a provider of custom peptides and antibodies. Biosynth is backed by private equity firms KKR and Ampersand Capital. Terms not …
The Walden Group Releases Q1 2022 Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its Q1 2022 Strategic Healthcare M&A Report, which includes: Market Overview Major M&A Deals by Sector What the Leading CEOs are Saying Performance of Leading Healthcare Companies Analysis of More Than 50 Q1 M&A Transactions …
The Walden Group was Engaged by Katalyst Surgical, LLC and Initiated Its Merger with Carl Zeiss Meditec AG
The Walden Group is pleased to announce that it was engaged by Katalyst Surgical, LLC and initiated its merger with an affiliate of Carl Zeiss Meditec AG, one of the world’s leading medical technology companies traded on the German Stock Exchange. Katalyst Surgical is a leader in vitreoretinal instruments, fiberoptic illumination, innovative light sources and other ophthalmic surgical technologies. Its …
Integer Acquires Aran Biomedical
Integer Holdings Corporation, a $1.2b device outsource manufacturer has acquired Ireland-based Aran Biomedical, a producer of proprietary medical textiles, high precision biomaterial coverings and coatings and advanced metal and polymer braiding for implantable devices. Aran Biomedical enables Integer to penetrate high growth cardiovascular markets including structural heart, neurovascular, peripheral vascular and endovascular and also general surgery applications. Deal terms – $130m …
Teamvantage Acquires MMD Medical
Custom contract manufacturer and injection molder Teamvantage has acquired MMD Medical, a contract manufacturer of components for large medical OEMs. The deal will enable Teamvantage to create a one-stop-shop with differentiated precision manufacturing capabilities. Teamvantage is a portfolio company of private equity firm Graham Partners. MMD Medical’s capabilities include injection molding, precision machining and mold building to scale the Teamvantage …
LumiThera Acquires Diopsys
LumiThera Inc, a manufacturer of photobiomodulation (PBM) technologies that treat ocular damage and disease, has acquired Diopsys, Inc. a maker of electrophysiology (ERG) devices that analyze visual and neuro-visual disorders. The deal adds an established commercial U.S. sales force to LumiThera’s EU sales team and a complimentary diagnostic and monitoring capability to LumiThera’s PBM platform. LumiThera’s device is being studied …
The Walden Group Releases 2021 Year-end Strategic Healthcare M&A Report
The Walden Group is pleased to provide access to its 2021 Year-end Strategic Healthcare M&A Report, which includes: Key Market Developments The Most Important M&A Deals What the Leading CEOs are Saying Top Deals > $100m in Transaction Value Announced or Closed in 2021 Performance …
DePuy Synthes Acquires CrossRoads Extremity Systems
DePuy Synthes, the orthopedics and neurosurgery division of J&J, has acquired CrossRoads® Extremity Systems from its majority investor, Healthpoint Capital. The deal adds a portfolio of implants and instruments for lower-extremity procedures. In December 2021, DePuy Synthes acquired Israeli-based OrthoSpin, maker of an robotic orthopedic strut systems for external circular fixations . CrossRoads’ EcoSMART instruments are reusable via sterile processing …
Smith & Nephew Acquires Engage Surgical for $135 Million
Smith & Nephew, a $4.6b UK-based sports medicine, joint repair, surgical access and woundcare technology producer, has acquired, Engage Surgical, a developer of a proprietary cementless partial knee system. The deal distinguishes Smith & Nephew as the only medical device company offering both cemented and cementless partial knee implants in the US, as well as robotics-assistance through the CORI Surgical …